The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Official Title: PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Study ID: NCT01617954
Brief Summary: This is a prospective study that will assess the impact of MammaPrint on chemotherapy + endocrine versus endocrine alone treatment decisions in patients with an Oncotype Intermediate Score.
Detailed Description: The frequency of chemotherapy + endocrine versus endocrine alone decisions in Oncotype DX intermediate score patients will be calculated before and after receiving the MammaPrint result.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Maricopa Integrated Health System, Phoenix, Arizona, United States
Providence Saint Joseph Medical Center, Burbank, California, United States
Comprehensive Cancer Center, Palm Springs, California, United States
Breastlink, Santa Ana, California, United States
Redwood Regional Cancer Center, Santa Rosa, California, United States
Exempla Saint Joseph Hospital, Denver, Colorado, United States
Stamford Hospital, Stamford, Connecticut, United States
The Breast Institute at JFK Medical, Atlantis, Florida, United States
Halifax Health Center for Oncology, Daytona Beach, Florida, United States
Broward Health Medical Center, Fort Lauderdale, Florida, United States
Regional Breast/21st Century Oncology, Fort Myers, Florida, United States
Northeast Georgia Cancer Care, Athens, Georgia, United States
Dekalb Medical Center, Decatur, Georgia, United States
Northeast Georgia Medical Center, Gainesville, Georgia, United States
Loyola University Medical Center, Chicago, Illinois, United States
Alexian Brothers Medical Center, Elk Grove Village, Illinois, United States
Delnor Community Hospital, Geneva, Illinois, United States
Ingalls Memorial Hospital, Harvey, Illinois, United States
Orchard Healthcare Research, Northbrook, Illinois, United States
CDH Cancer Center, Winfield, Illinois, United States
IU Health Bloomington, Bloomington, Indiana, United States
Northern Indiana Cancer Research Consortium, South Bend, Indiana, United States
Covenant Medical Center, Waterloo, Iowa, United States
MedStar Harbor Hospital, Baltimore, Maryland, United States
Harry & Jeanette Weinberg Cancer Institute at Franklin Square, Baltimore, Maryland, United States
Mercy Medical Center, Baltimore, Maryland, United States
Western Maryland Health System, Cumberland, Maryland, United States
Lahey Clinic, Burlington, Massachusetts, United States
Mount Auburn Hospital, Cambridge, Massachusetts, United States
MetroWest Medical Center, Framingham, Massachusetts, United States
St. Vincent Hospital, Worcester, Massachusetts, United States
Detroit Clinical Research Center, Detroit, Michigan, United States
Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States
St. Louis Cancer Care, Bridgeton, Missouri, United States
SSM Cancer Center, St. Louis, Missouri, United States
Roswell Park Cancer Center, Buffalo, New York, United States
North Shore/Monter Cancer Center, Lake Success, New York, United States
Columbia University, New York, New York, United States
University of Oklahoma, Oklahoma City, Oklahoma, United States
Tulsa Cancer Institute, Tulsa, Oklahoma, United States
St. Mary Medical Center, Langhorne, Pennsylvania, United States
St. Clair Hospital, Pittsburgh, Pennsylvania, United States
Charleston Cancer Center, Charleston, South Carolina, United States
Cookeville Regional Medical Center, Cookeville, Tennessee, United States
Knoxville Comprehensive Breast Center, Knoxville, Tennessee, United States
Nashville Breast Center, Nashville, Tennessee, United States
Texas Health, Dallas, Texas, United States
Hematology/Oncology Associates, Alexandria, Virginia, United States
Lynchburg Hematology Oncology Clinic, Lynchburg, Virginia, United States
Swedish Cancer Institute, Seattle, Washington, United States
Columbia St. Mary's Cancer Center, Milwaukee, Wisconsin, United States
Aurora Advanced Healthcare, Milwaukee, Wisconsin, United States
Wheaton Franciscan Cancer Care - All Saints, Racine, Wisconsin, United States
Name: Michaela Tsai, MD
Affiliation: Piper Breast Center
Role: PRINCIPAL_INVESTIGATOR